Stifel Financial’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-17,722
Closed -$172K 3332
2022
Q3
$172K Buy
17,722
+1,615
+10% +$21.4K ﹤0.01% 2993
2022
Q2
$233K Sell
16,107
-4,055
-20% -$69.1K ﹤0.01% 2890
2022
Q1
$527K Sell
20,162
-13,144
-39% -$373K ﹤0.01% 2547
2021
Q4
$1.32M Sell
33,306
-6,239
-16% -$284K ﹤0.01% 1913
2021
Q3
$1.98M Buy
39,545
+3,326
+9% +$181K ﹤0.01% 1586
2021
Q2
$2.01M Buy
36,219
+1,690
+5% +$90K ﹤0.01% 1610
2021
Q1
$1.61M Sell
34,529
-14,013
-29% -$679K ﹤0.01% 1652
2020
Q4
$2.11M Buy
48,542
+18,850
+63% +$695K ﹤0.01% 1355
2020
Q3
$1.09M Buy
29,692
+2,697
+10% +$91.6K ﹤0.01% 1571
2020
Q2
$788K Buy
+26,995
New +$746K ﹤0.01% 1722

Other funds holding HCAT